[CLSTR]
API
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [TECHNOLOGY]

3 clusters · 7 sources · 21 days · First seen · Last updated

OpenAI GPT-Rosalind life sciences model expansion

Overview

OpenAI has begun structuring its GPT-Rosalind series into a specialized product line for the life sciences sector. Following the introduction of pricing for the gpt-rosalind-discovery and gpt-rosalind-research models, the company has expanded its reach through the Rosalind Academic Plan.

This academic program provides eligible US university laboratories with access to specialized biological research AI tools, including up to 30 Business Standard seats for 12 months. To support fields such as drug discovery and translational medicine, the models are designed to synthesize scientific literature and plan experiments. To address privacy concerns, OpenAI stated that research data from these academic accounts will not be used to train its models by default.

On October 30, 2026, OpenAI released GPT-Rosalind-6, a frontier reasoning system for biology and drug discovery. Available exclusively to vetted scientists, research institutes, companies, and government partners, the model utilizes existing GPT-6 Astra weights with modified deployment boundaries and safety protocols rather than additional training. While the model achieved a 100 percent success rate on benign biological questions, OpenAI noted a decrease in refusal rates for sensitive biosafety queries, dropping to 79.0 percent from 99.8 percent in the base model. Consequently, OpenAI has classified the system as high risk in biology and chemistry, and critical in cybersecurity.

Entities

OpenAI · Amgen · GPT-Rosalind-6 · GPT-Rosalind · Moderna

Timeline

  1. [TECHNOLOGY] 2 sources
    OpenAI restricts access to GPT-Rosalind-6 biology model

    OpenAI launched GPT-Rosalind-6, a specialized reasoning model for biology and drug discovery, featuring restricted access for vetted researchers and modified safety protocols.

  2. [TECHNOLOGY] 3 sources
    OpenAI expands GPT-Rosalind access for academic research

    OpenAI is expanding access to its GPT-Rosalind model through a new academic plan, offering sponsored access to US university biology labs to support drug discovery and scientific research.

  3. [TECHNOLOGY] 2 sources
    OpenAI expands life sciences model lineup with new pricing

    OpenAI has added gpt-rosalind-discovery to its API pricing, expanding its GPT-Rosalind life sciences model series.

Sources

ad-hoc-news.de · completesports.com · cryptobriefing.com · linformatique.org · ontheissuesmagazine.com · the-decoder.com · tokenpost.kr

This summary has been updated 1 time: see revision history